Arabic Arabic English English French French German German
dark

Inclusion of Kintor as a Constituent Stock of HSCI

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company’s stock has been included in the Hang Seng Composite Index, effective September 6, 2021. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China

Next Post

Atradius – Global economy “recovering fully”

Related Posts
Total
0
Share